Roles of Nogo-B receptor in maintaining the structural integrity of blood vessels
Roles of Nogo-B receptor in maintaining the structural integrity of blood vessels
批准号:
10254256
负责人:
QING MIAO
金额:
$51.18万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-20 至 2024-06-30
关键词:
Automobile DrivingBindingBlood VesselsBrainCCM1 geneCaliberCell Surface ReceptorsCell membraneCellsCerebral hemisphere hemorrhageCerebrovascular systemDataDefectDevelopmentDiagnosisElementsEndothelial CellsEndotheliumEtiologyExhibitsFDA approvedFamilyFunctional disorderFundingGene ExpressionGene Expression RegulationGene FamilyGenesGeneticGenetic TranscriptionGerm-Line MutationGoalsHeadacheHealthHistologyHumanImpairmentIn VitroIntercellular JunctionsIntracranial HemorrhagesKnockout MiceKnowledgeLeadLesionLinkMediatingMembraneMissionMolecularMorphogenesisMusNeurologicNeurologic DeficitNuclear TranslocationPathogenesisPathway interactionsPatientsPatternPericytesPharmaceutical PreparationsPhenotypePlayPromoter RegionsRas Signaling PathwayReportingResearchRiskRisk FactorsRoleSeizuresSignal PathwaySmall Interfering RNASpinalStructureTestingTissuesTranscriptTranscriptional ActivationUnited States National Institutes of HealthYolk Sacangiogenesisbasebrain endothelial cellcell assemblycerebral cavernous malformationscerebrovascularcerebrovascular lesiondisabilityhuman datahuman subjectimprovedin vivoinsightloss of function mutationmalformationnovelnovel therapeutic interventionpolarized cellpreventreceptorreceptor bindingreceptor expressionrecruitstroke risktherapy developmenttranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT
Cerebral cavernous malformations (CCMs), which can occur in 1 out of every 200 people in the US, cause
seizure and cerebral hemorrhage. Previous studies have shown that decreased expression or a loss-of-function
mutation of CCM family genes (CCM1, CCM2, CCM3) causes CCMs. Although the genetic origins of familial
CCMs (20% of cases) have been well characterized, the etiology of sporadic CCMs (80% of cases) that do not
carry a germline mutation in CCM genes remains to be established. The long-term goal of our research is to
determine if and the extent to which Nogo-B receptor (NgBR) deficiency plays a causal role in the etiology of
sporadic CCMs. Support for this idea comes from our previous R01-funded studies where we not only elucidated
the molecular mechanisms by which NgBR binds farnesylated Ras to promote angiogenesis but also identified
that the NgBR-mediated Ras pathway regulates the expression and activation of transcription factors in
endothelial cells. Interestingly, these transcription factors have their binding elements in the promoter regions of
CCM1 and CCM2 genes. Consequently, transcript levels of CCM1 and CCM2 genes decrease in NgBR-deficient
human brain endothelial cells in vitro and in the yolk sac of NgBR endothelial cell-specific knockout (ecKO) mice
in vivo. Additional support of the NgBR-CCM connection comes from histology studies showing that NgBR
immunostaining intensity is significantly decreased in endothelial cells (ECs) of human sporadic CCM lesion
tissue sections. NgBR ecKO mice have aberrant patterns of cerebral blood vessel assembly, which results in
defective EC polarization and the formation of dilated blood vessels. This phenotype is surprisingly similar to the
CCM lesions. In addition, the pericyte layer around blood vessels in NgBR ecKO mice is much thinner than
littermate control mice. This means that endothelial NgBR deficiency can actually impair pericyte recruitment,
which is known as essential for maintaining the structural integrity of blood vessels. Based on these findings, we
hypothesize that the NgBR-Ras signaling pathway regulates CCM1/2 expression, and that disrupting this
signaling pathway results in cerebrovascular malformation. We will test this hypothesis in three aims. Aim 1:
Determine the role of the NgBR-CCM1/2 axis in regulating EC polarization and cerebral blood vessel assembly;
Aim 2: Determine the role of the NgBR-CCM1/2 axis in maintaining pericyte recruitment and the structural
integrity of cerebral blood vessels; Aim 3: Determine the mechanisms by which NgBR regulates CCM1/2
transcription and the contributions of NgBR-Ras pathway deficiency to the pathogenesis of sporadic CCM. The
studies proposed here will establish clear links between NgBR, CCM1/2, and cerebrovascular malformation.
Findings from our studies will provide new insight into how NgBR and NgBR-regulated factors guide CCM1/2
expression in brain ECs, and maintain the structural integrity of cerebral blood vessels.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3389/fcell.2021.672447
发表时间:
2021
期刊:
Frontiers in cell and developmental biology
影响因子:
5.5
作者:
[Fang Z, Wang X, Sun X, Hu W, Miao QR]
通讯作者:
Miao QR
DOI:
10.1172/jci151382
发表时间:
2022-05-02
期刊:
JOURNAL OF CLINICAL INVESTIGATION
影响因子:
15.9
作者:
[Fang, Zhi, Sun, Xiaoran, Wang, Xiang, Ma, Ji, Palaia, Thomas, Rana, Ujala, Miao, Benjamin, Ragolia, Louis, Hu, Wenquan, Miao, Qing Robert]
通讯作者:
Miao, Qing Robert
DOI:
10.1039/d0bm00873g
发表时间:
2020-09-21
期刊:
Biomaterials science
影响因子:
6.6
作者:
[]
通讯作者:
Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver
-
批准号:10634069
-
项目类别:
-
资助金额:$62.99万
-
财政年份:2023
-
负责人:QING MIAO
-
依托单位:
Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance
-
批准号:10418590
-
项目类别:
-
资助金额:$58.56万
-
财政年份:2022
-
负责人:QING MIAO
-
依托单位:
Role of NgBR in regulating hepatic gluconeogenesis and insulin resistance
-
批准号:10596140
-
项目类别:
-
资助金额:$59.25万
-
财政年份:2022
-
负责人:QING MIAO
-
依托单位:
Role of NgBR in Hepatic Steatosis
-
批准号:10439176
-
项目类别:
-
资助金额:$40.82万
-
财政年份:2019
-
负责人:QING MIAO
-
依托单位:
Role of NgBR in Hepatic Steatosis
-
批准号:9981481
-
项目类别:
-
资助金额:$41.98万
-
财政年份:2019
-
负责人:QING MIAO
-
依托单位:
Role of NgBR
-
批准号:8518447
-
项目类别:
-
资助金额:$35.7万
-
财政年份:2011
-
负责人:QING MIAO
-
依托单位:
Role of NgBR
-
批准号:8322683
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:QING MIAO
-
依托单位:
Role of NgBR
-
批准号:8699258
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2011
-
负责人:QING MIAO
-
依托单位:
Role of NgBR
-
批准号:8155314
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2011
-
负责人:QING MIAO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: